IDENTIFICATION OF A CUT-OFF FOR PERSISTENT ANTI-INFLIXIMAB ANTIBODIES AS A PREDICTOR OF RESPONSE TO INFLIXIMAB MONOTHERAPY

被引：0
|
作者：
Del Nero, L. [2 ]
Bodini, G. [2 ]
Giannini, E. G. [2 ]
Savarino, V [2 ]
De Maria, C. [2 ]
Baldissarro, I [2 ]
Savarino, E. [1 ]
机构：
[1] Univ Padua, Dept Surg Oncol & Gastroenterol, Gastroenterol Unit, Padua, Italy
[2] Univ Genoa, Dept Internal Med, Gastroenterol Unit, Genoa, Italy
来源：
DIGESTIVE AND LIVER DISEASE | 2016年 / 48卷
关键词：
D O I：
10.1016/S1590-8658(16)30027-5
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
OC.02.6
引用
收藏
页码：E77 / E77
页数：1
相关论文
共 50 条
  • [31] Anti-infliximab antibodies are eliminated more rapidly in vivo than non-immune antibodies in the presence of infliximab
    Rojas, J
    Rutkoski, T
    Vennarini, J
    Jang, H
    Wagner, CL
    [J]. FASEB JOURNAL, 2003, 17 (07): : C138 - C138
  • [32] Exploring the Binding Sites of Anti-Infliximab Antibodies in Pediatric Patients With Rheumatic Diseases Treated With Infliximab
    Kosmac, Miha
    Avcin, Tadej
    Toplak, Natasa
    Simonini, Gabriele
    Cimaz, Rolando
    Serbec, Vladka Curin
    [J]. PEDIATRIC RESEARCH, 2011, 69 (03) : 243 - 248
  • [33] Anti-infliximab antibodies: How to compare old and new data?
    Imbrechts, Maya
    Van Stappen, Thomas
    Compernolle, Griet
    Tops, Sophie
    Gils, Ann
    [J]. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2020, 177
  • [34] Influence of anti-infliximab antibodies and residual infliximab concentrations on the occurrence of acquired drug resistance to infliximab in rheumatoid arthritis patients
    Finckh, Axel
    Dudler, Jean
    Wermelinger, Felix
    Ciurea, Adrian
    Kyburz, Diego
    Gabay, Cem
    Bas, Sylvette
    [J]. JOINT BONE SPINE, 2010, 77 (04) : 313 - 318
  • [35] Letter: persistence of anti-infliximab antibodies after discontinuation of infliximab in patients with IBD - authors' reply
    Ben-Horin, S.
    Chowers, Y.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2012, 36 (05) : 501 - 501
  • [36] The Clinical and Immunological Significance of Low Level of Infliximab in the Absence of Anti-Infliximab Antibodies in Patients With IBD
    Ungar, Bella
    Anafy, Adi
    Kopylov, Uri
    Ron, Yulia
    Yanai, Henit
    Dotan, Iris
    Chowers, Yehuda
    Eliakim, Abraham R.
    Ben-Horin, Shomron
    [J]. GASTROENTEROLOGY, 2014, 146 (05) : S245 - S245
  • [37] Anti-infliximab antibodies are eliminated more rapidly in vivo than non-immune antibodies in the presence of infliximab
    Rojas, J
    Rutkoski, T
    Vennarini, J
    Jang, H
    Wagner, CL
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2003, 62 : 175 - 175
  • [38] Exploring the Binding Sites of Anti-Infliximab Antibodies in Pediatric Patients With Rheumatic Diseases Treated With Infliximab
    Miha Kosmač
    Tadej Avčin
    Nataša Toplak
    Gabriele Simonini
    Rolando Cimaz
    Vladka Čurin Šerbec
    [J]. Pediatric Research, 2011, 69 : 243 - 248
  • [39] InfliximabDevelopment of anti-infliximab antibodies, rash and fever: case report
    [J]. Reactions Weekly, 2019, 1775 (1) : 259 - 259
  • [40] Therapeutic drug monitoring countering the effect of anti-infliximab antibodies
    Hooijberg, Femke
    Wolbink, Gertjan
    [J]. LANCET RHEUMATOLOGY, 2024, 6 (04): : e193 - e194
12345